Psoriasis and psoriatic arthritis (PsA) are related inflammatory diseases with some shared genetic and environmental risk factors. It has been suggested that environmental factors, including infections, can trigger the development of PsA among psoriasis patients. The aim of this review was to systematically examine available data evaluating the effect of infections on the risk of developing PsA. A systematic search of the Cochrane Library, PubMed, Scopus, and Web of Science was conducted on March 16 2017, in accordance with the PRISMA statement. The following search terms were used along with "psoriatic arthritis": "infections", "risk", "bacteria", and "virus". Abstracts were reviewed and publications meeting the following criteria included: (1) Observational studies on psoriasis and PsA patients, including case-control, cohort, or ecologic studies and (2) presenting original data on the association between infections and PsA. The protocol for this systematic review was registered on PROSPERO (ID: 79432). Twenty-seven original studies presenting data on infections among PsA patients were included. Eight studies showed a statistically significant association between infections and PsA. In addition, seven studies reported mixed result with some statistically significant associations and five studies did not find statistically significant associations. This included studies of bacterial as well as viral pathogens and those of infections in general. The remaining seven studies lacked data to determine statistical significance. Out of all included studies, the total number of included patients was 933 PsA patients and 1611 controls. While the studies summarized did not all provide evidence supporting an association between infections and PsA certain trends emerged. The available data are inconsistent and further studies are needed to verify or refute this purported association. In particular, laryngeal infections and infections involving streptococci should be studied more carefully.
Introduction
Psoriasis is a chronic inflammatory skin disease affecting 2-3% of the population [1] . The inflammatory joint arthritis psoriatic arthritis (PsA) is closely related to psoriasis and can be found in 5-42% of psoriasis patients [2] . PsA has a major impact on patient health and quality of life [3] . Strong heritability is seen in PsA and specific Human Leukocyte Antigen (HLA) antigens appear to confer susceptibility, but genetic factors do not account for all cases [4, 5] . It has been suggested that psoriasis patients with predisposing genetic factors may develop PsA after exposure to triggering environmental factors [6] , but the particulars, including effect sizes, remain largely unclear.
Environmental factors associated with psoriasis include streptococcal pharyngitis, stressful life events, humidity, human immunodeficiency virus (HIV) infection, trauma, smoking, drugs, cold weather, diet, and obesity [7] [8] [9] [10] . Similarly, studies have suggested that PsA may be associated with Rubella vaccination, infections, HIV infection, obesity, smoking, recurrent oral ulcers, moving home, trauma, physically demanding occupations, and fractured bone requiring hospital admission [11] [12] [13] [14] [15] . Longitudinal population-based studies showed that the relative risk (RR) for developing PsA among psoriasis patients was 1.48 among those with a body mass index (BMI) over 35 [14] and 6.46 in a study of women only [16] . In a longitudinal matched cohort study, physical trauma recorded in primary care was associated with PsA among psoriasis patients with a multivariate hazard ratio (HR) of 1.32 for any trauma, 1.46 for bone trauma, and 1.50 for joint trauma [13] . Previously published data have also suggested that exposure to infection-related triggers might be of relevance [12, 15] .
The principal aim of this study is to systematically review available data evaluating the effects of infections on the risk of developing PsA.
Methods

Systematic literature search
A systematic literature search of the Cochrane Library, PubMed, Scopus, and Web of Science was conducted on March 16 2017, in accordance with the preferred reporting items for systematic review and meta-analysis (PRISMA) guidelines [17] . The following search terms were used along with "psoriatic arthritis": "infections", "risk", "bacteria", and "virus". The search was further limited to articles with available abstracts and published in English. No time frame was fitted for the search nor regarding the publication status. As an example, the search strategy employed was as follows: [(psoriatic arthritis AND infections) OR (psoriatic arthritis AND risk) OR (psoriatic arthritis AND bacteria)] OR (psoriatic arthritis AND virus). The protocol for this systematic review was registered on PROSPERO (ID: 79432).
Study selection
Duplicate publications were removed and abstracts and titles of the remaining publications screened for eligibility. Full texts of articles were obtained for all publications that appeared to meet the inclusion criteria, likewise if there was any uncertainty. Both authors screened the publications in terms of content. When uncertainty rose about whether a publication should be included or not, it was discussed by both authors. Publications meeting the following criteria were included: (1) observational studies on psoriasis and PsA patients, including case-control, cohort or ecologic studies and (2) presenting original data on the association between infections and PsA. Articles including data on five or fewer PsA cases were excluded from the review as they share more features with case reports than observational studies. Figure 1 shows the progression of the database search and study selection. Included studies were parsed to categories of bacterial infections, viral infections, and infections, in general. 
Data extraction
Data were extracted directly from each eligible study. Data extracted included information about study design, study groups, how the exposure to infection was examined, adjusted covariates, and the result. When p values were published in comparison between groups, they were likewise extracted. All data were extracted with a predefined structured form. Both authors contributed to the work of clarifying the included studies.
Statistical analyses
When p values were missing for comparison between groups, they were calculated by Fisher's exact test if sufficient data were available in the published article.
Results
Search results
The search yielded 4747 articles, after the removal of duplicates. No additional publications were identified from other sources. Altogether, 4579 articles with no data on the association between infection and PsA were excluded after screening of title and abstract, as well as 88 articles that did not present original data. Thirty-eight case reports and studies including 5 or fewer PsA cases were also excluded from the review but are briefly described for completeness.
Twenty-seven original studies presenting data on infections among PsA patients were included: 6 case-control studies, 20 cross-sectional studies, and 1 cohort study. Study design, country, exposure (i.e. infection), number of PsA patients and controls, and risk estimates/results for the included studies are summarized in Tables 1, 2 and 3, parsed into categories of bacterial infections, viral infections, and infections in general. Out of all included studies, the total number of included patients was 933 PsA patients and 1611 controls.
Bacterial infections
Seventeen included studies examined bacterial infections and six of them found an association with PsA (Table 1 ). In addition, five studies reported mixed result with some statistically significant associations.
Gram-positive bacterial infections
Streptococcal infections were the subject of six studies and were found to be associated with the development of PsA in four [18] [19] [20] [21] . Vasey and colleagues found that 51% of 49
PsA cases were anti-DNase-B positive compared to 10% among normal controls, p < 0.0001 [20] . They also described increased reactivity among peripheral PsA as compared to axial PsA, p < 0.05. Three studies found an association between PsA and Streptococcus pyogenes. Higher immune responses to Streptococcus pyogenes rM12 protein (AB and C regions) and IgG antibody levels against each region were observed in 31 PsA patients compared to 88 psoriasis vulgaris patients, 6 Rheumatoid Arthritis (RA) patients, and 77 healthy controls by Muto and colleagues [18] . Wang and colleagues similarly demonstrated higher levels of 16S rRNA of Streptococcus pyogenes in the blood of 19 PsA cases compared to 17 RA patients and 10 other arthritis patients [21] . Rantakokko and colleagues measured IgM, IgA, and IgG serum antibodies against peptidoglycan-polysaccharide (PG-PS) and peptidoglycan (PG) from Streptococcus pyogenes in 38 PsA cases and 34 controls and found statistically significant association with IgA-PG-PS [19] .
Two of the seven studies exploring associations between PsA and streptococcal infections found no statistically significant connection [22, 23] . Thumboo and colleagues' population-based nested case-control study matched 60 PsA patients with 120 psoriasis controls and found that PsA patients were not more likely to have had a positive streptococcal culture within a period beginning 2 years before the onset of psoriatic disease, p = 0.528 (95% CI 0.29-1.90) [23] . Responses to three streptococcal antigens were not statistically significantly different between 21 PsA cases and 15 age-matched controls in a study by Grinlinton and colleagues [22] .
Two studies demonstrated an association between staphylococcal super antigens and PsA [24, 25] . Rahman and colleagues measured serum antibody levels to staphylococcal antigens in 110 patients with various diseases and found statistically significantly higher titers among 22 PsA patients compared to 16 psoriasis patients [24] , while Yamamoto and colleagues found a statistically significant difference in mononuclear cell responses in 11 PsA patients compared to normal controls [25] .
Gram-negative bacterial infections
A possible role for Chlamydia trachomatis (CT) infections was explored in two studies [26, 27] . Silveira et al. collected urethral and endocervical specimens for detection of CT, along with serum for determination of IgG and IgM antibodies. Although they focused on reactive arthritis, they found that of 18 patients with PsA 22.2% had a positive culture for CT, but no control group was available. Furthermore, of 14 PsA patients tested, 35.7% had serum IgG and 14.3% IgM antibodies, which was not statistically significantly different from a control group of 60 individuals, p = 0.06 and 0.09 [27] . Lapadula and colleagues found that 22 PsA [26] . Previously, Lapadula and colleagues studied the occurrence of anti-bacterial antibodies among seronegative spondyloarthropathy (SNSA) patients. They compared sera from 101 patients with different rheumatic diseases, including 7 PsA cases, to sera from 31 healthy donors. They found a statistically significant difference in antibody production against Yersinia enterocolitica, Campylobacter intestinalis, and Yersinia pseudotuberculosis between the healthy donors and the seronegative polyarthritis patients [28] . All the studies on antibody titers were cross-sectional, and no data presented on the temporal relationship between measured antibody titers and onset of disease. In a study focused on psoriasis by Stinco and colleagues, Chlamydophila psittaci DNA-positive samples were not statistically significantly more common among 12 PsA patients than in the general population with an odds ratio (OR) of 20.36 (95% CI 1.2-347.6), p = 0.1 [29] . On the other hand, in a study by Fabris and colleagues, Chlamydophila psittaci infections were associated with PsA with an OR of 44.8 (95% CI 5.21-385.2), p < 0.0001 [30] . Trull and colleagues focused on ankylosing spondylitis (AS) patients but included PsA patients, RA patients, and healthy controls as comparison. They measured IgA levels for Klebsiella pneumoniae but found no difference between the 35 PsA patients and 57 normal controls [31] . One study compared gut bacteria from patients with NORA (new-onset rheumatoid arthritis), CRA (chronic, treated rheumatoid arthritis), PsA, and healthy controls. The prevalence of P.copri among the 16 PsA cases included was 37.5% compared to 21.4% among the healthy controls, p = 0.3032 [32] .
Non-type-specific bacterial infections
Two studies were not specific for type of bacterial infections. Moen and colleagues examined oral bacterial DNA based on the hypothesis that bacteria may perpetuate autoimmunity in joint disease. Statistically significantly higher numbers of bacterial species and higher concentrations were found in the PsA and RA groups compared to controls [33] . Finally, association of recent infection requiring antibiotics as a possible risk factors was examined in a prospective cohort study of 464 psoriasis patients by Eder et al. The patients had not been diagnosed with PsA at the study enrollment and were followed up for 8 years. A total of 51 patients developed PsA in the follow-up time and association with recent infection requiring antibiotics were not statistically significant with an RR of 0.88 (CI 0.39-1.98) in an analysis controlled for age at onset of psoriasis and stratified by sex [34] .
Viral infections
Seven included studies examined viral infections, with HIV infection being the most common subject (Table 2 ).
Human immunodeficiency virus (HIV) infection
HIV infections were the subject of three included studies [35] [36] [37] . Louthrenoo et al. examined 100 HIV infected patients with musculoskeletal symptoms (including 9 PsA patients) and showed that the HIV infection had been documented before the development of musculoskeletal symptoms in 31 patients [35] . HIV antibodies were measured in 595 new consecutive attendees in an arthritis clinic in Zambia by Njobvu and colleagues. The prevalence of HIV infection among the 13 PsA cases was 92% compared to approximately 50% among hospital outpatients and 30% of the adult urban population during the period [37] . Another report by Njobvu and McGill described that among 702 inflammatory arthritis patients attending an arthritis clinic in Zambia, 28 had PsA of whom 96% had HIV [36] . These two studies from Zambia appear to be partially based on the same patient pool. The authors note that the prevalence of PsA in their study appeared to be 25-fold higher than in European populations, in areas where PsA was previously rare, and that it appears to be linked to HIV infection which is more common in this area.
Hepatitis C virus (HCV) infection
Two included studies explored Hepatitis C virus (HCV) infection [38, 39] . Taglione and colleagues found anti-HCV antibodies in the sera of 12% of PsA cases compared to 5.2% in RA and 3.2% in historical controls in the general population reported in another study [40] , p = 0.11 and 0.0004, respectively [39] . On the other hand, Palazzi and colleagues found no statistically significant difference in the prevalence of HCV antibodies between 100 PsA patients and 100 controls with Osteoarthritis (OA) or sciatica [38] .
Viruses in synovium
Mehraein and colleagues have published two reports on viruses in the synovium of patients with inflammatory arthritis, with data on Parvovirus B19, Cytomegalovirus (CMV), and Epstein-Barr virus (EBV) [41, 42] . They found that patients with PsA and RA were more likely to have evidence of replicating Parvovirus B19 in their synovium than patients with reactive arthritis/synovitis (ReA/S) [42] . The proportion of cases expressing B19 virus protein was especially high in the RA cases (89.7%) and to a lesser extent in the PsA cases with 66% compared to 38.5% in the ReA/S cases. The proportion was higher among the 6 PsA cases compared to the two normal controls or 66 vs. 50%, p = 1.000 [42] . CMV-DNA was detected in 50% of PsA cases, and 31% of RA cases vs. 11.6% in the ReA/S cases. Compared to normal controls, the proportion was higher among the PsA cases or 50 vs. 0%, p = 0.46. Finally, they found that PsA and RA patients were more likely than ReA/S patients to have more than one of these viruses simultaneously present [41] .
Infections in general
Four of the included studies were not pathogen-specific but explored infections in general (Table 3 ). Pattison and colleagues studied 98 cases of PsA and found a statistically significant association between PsA and recurrent oral ulceration with an OR of 4.2 (95% CI 1.96-9.0), which the authors suggest, maybe, a proxy for recent exposure to infection [12] . No association was found with infective diarrhea or conjunctivitis in this study. Eder and colleagues explored the association between environmental factors and the onset of PsA among psoriasis patients. The study population consisted of 159 patients with recent onset PsA and 159 psoriasis patients without arthritis who were asked if they had been exposed to hypothesized triggers, including infections, in the previous 10 years. Statistically significant association with infections that required antibiotics was found with an OR of 1.7 (95% CI 1.00-2.77) [15] . No association was found with infective diarrhea. Brzewski and colleagues collected data from consultations to examine the role of focal infections in psoriasis and urticaria. Laryngeal foci of infection were more common among 16 PsA cases than among 85 psoriasis cases, 43.75 vs. 17.65%, p = 0.028, while the rates of gynecological foci of infection were similar [43] . Finally, Eder and colleagues published the results of a prospective cohort study of 464 psoriasis patients where 51 patients developed PsA during 8 years of follow-up. Association with recent infection was not statistically significant with an RR 0.96 (CI 0.52-1.77) in an analysis controlled for age at onset of psoriasis and stratified by sex [34] .
Case reports and studies with 5 or fewer PsA cases
Case reports and studies including 5 or fewer PsA cases were excluded from the review but warrant a brief mention. Most considered the same pathogens as the included studies, i.e., CT, staphylococcus, streptococcus, EBV, HCV, HIV, CMV, and Parvovirus B19. Schaeverbeke and colleagues collected 209 synovial fluid samples over a 30-month period, half from inflammatory rheumatic disease patients and the remaining from patients with other conditions. The samples were cultured for Streptococcus Pyogenes, Mycobacterium, and Mycoplasma. They detected Mycoplasma in 8 samples, most from RA patients, but one of the 5 included PsA patients had a positive culture for Mycoplasma hominis [44] . Johnson and colleagues examined synovial fluid samples from 26 RA patients, 10 OA patients, and 8 patients with other inflammatory arthritis, including 2 PsA cases. They found Mycoplasma fermentans in nearly all (88%) of the non-rheumatoid inflammatory arthritis cases, including 1 of the 2 PsA cases [45] . One case report on Salmonella typhimurium described a PsA patient in remission for 5 years who developed severe PsA within 2 weeks of a Salmonella typhimurium infection [46] .
Discussion
The idea of a possible triggering role for infections in the pathogenesis of PsA is anything but novel. A case report from 1979 discussed a patient with a history of Varicella virus infection 2 weeks before the onset of PsA, which might have triggered the arthritis [47] . The studies reviewed here suggest a role for infections, but whether there is a true association between infections and the development of PsA among psoriasis patients remains to be determined.
This review describes 27 studies exploring this purported association. As PsA is an uncommon disease, unsurprisingly most of the studies were cross-sectional. Eight of the 27 studies showed a statistically significant association between infections and PsA. In addition, seven studies reported mixed result with some statistically significant associations. Five studies did not find statistically significant associations. This included studies of bacterial pathogens as well as viral infections and infections, in general. Two studies presented data from in Zambia which, in the view of their authors, support the hypothesis that infections are linked with PsA but did not present statistical analysis to support those claims. The remaining five studies neither presented a statistical analysis, nor enough data to allow readers to perform such analyses. Thus, 15 of the 20 studies that presented enough data for statistical analysis support a statistically significant association between infections and PsA. The risk of publication bias cannot be excluded, that is a bias of published data concerning positive results of association between infections and PsA.
There was more evidence for an association between PsA and exposure to Gram-positive bacteria than to Gramnegative bacteria. Notably, streptococcal infections were often studied, perhaps due to their better described association with skin psoriasis, where they are known to trigger or exacerbate psoriasis [48] . One of the studies reviewed here included data supporting a possible link between laryngeal infections and PsA [43] . This is particularly interesting given the literature on skin exacerbations linked to sore throat and streptococcal infections [48] as well as reports on the benefit of tonsillectomy as a treatment for psoriasis [49] . Interestingly, Eder and colleagues found an association between infections and PsA when subjects were asked about past infections requiring antibiotics, but when they studied the question prospectively, a protective effect emerged, although it did not reach statistical significance. Possible explanations include retrospective bias in the first study, but it would be wise to also consider the possibility that antibiotic treatment could modify the effect otherwise associated with sore throat, creating the appearance of a protective effect of infection. Based on these findings, future studies should, therefore, consider the infectious agent, the location of infection, and any treatment received when trying to decipher the role of infection in PsA.
Included studies presenting data from sub-Saharan Africa suggest a dramatic role for HIV infection in the development of PsA. However, there is a lack of studies with an unexposed control group, i.e., without HIV infection. These studies are also hampered by the limited access to healthcare in this area which is contingent on personal finances. These issues aside, PsA seems to be rare in HIV-negative individuals in sub-Saharan Africa, thus supporting the claim that the observed rates among HIV infected patients are, indeed, increased [36] . This possible link between HIV infection and PsA is more likely to provide insights into the pathogenesis of this disorder than to provide opportunities for public health interventions, as the treatment and eradication of HIV from human populations is pressing regardless of the presence of autoimmune disease.
Biological plausibility
The potential for infections to play a role in the development of PsA among psoriasis patients is biologically plausible, as PsA is thought to be caused by dysregulation of the immune system and the balance of the immune system is upset by infection. More specifically, Toll-like receptors (TLRs) play a role in immunoregulation in bacterial infection, and TLR2 and TLR4 can activate innate immune cells in response to Gram-positive and Gram-negative bacteria, respectively [50] . Monocytes in PsA patients have an increased number of TLR2 receptors compared to healthy controls, suggesting that Gram-positive bacteria exposure could induce a more pronounced inflammatory response in PsA [50] . On the other hand, psoriasis and PsA patients are at increased risk of infection. The increased risk is multiplex, there is a loss of integrity of the skin barrier, cellular immunity is altered, and many patients receive immunosuppressive therapy, e.g., with biologics.
There is clear evidence of exacerbation of psoriatic disease among HIV patients. Likewise, mounting evidence suggests that the prevalence of psoriatic disease is increased among HIV patients [51] . The link between HIV infection and psoriatic disease might be explained by the pathogenesis of HIV, which involves decreasing number of CD4 + T cells, but psoriatic disease is thought to be largely T-cell mediated [52] . It has been suggested that HIV infection creates an environment conducive to psoriasis, i.e., by decreasing the number of CD4 + T cells and increasing the number of CD8 + T cells [52] . Joints of PsA patients have been found to be enriched in IL-17 + CD8 + T cells, and the amount of these cells detected seems to correlate with disease activity and progression of joint damage [53] . Thus, the changes in T-cell-mediated immunity associated with HIV may create an environment compatible with psoriatic disease.
Limitations and avenues for further investigation
This review is limited both by the quality of the available data as well as some shortcomings of the review process. Ideally, this paper would include a meta-analysis, but the available data did not allow for one. The search was limited to publications with available abstracts published in English, so published data in other languages may have been missed.
Studies presenting data on antibody titers were limited by their cross-sectional design which prevented them from determining if exposure occurred before or after the onset of PsA. Furthermore, as the immune system may be somewhat stimulated at baseline in PsA patients resulting in higher antibody titers, in general, such results must be interpreted with caution. Some included studies entail a risk of recall bias when subjects recall 10 years or more of history of exposure. Perhaps, the most obvious shortcoming is the small number of PsA cases in most studies reviewed.
Despite these limitations, there are clear suggestions of an association in several studies exploring laryngeal and streptococcal infections as a possible pathogenic factor for the onset of PsA and these merit further study.
Conclusion
This systematic review provides an overview of available data evaluating the effect of infections on the risk of developing PsA. The data summarized here do not provide evidence of a clear association between infections in general and the development of PsA. However, the data were inconsistent and suggest that some types of infection merit further study. Future studies should focus on the site of infection and its treatment, as well as on the infectious agent.
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